Pioglitazone Hydrochloride

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Pioglitazone hydrochloride 33.07mg equivalent to 30 mg pioglitazone

Disponible depuis:

Dr Reddy's New Zealand Limited

DCI (Dénomination commune internationale):

Pioglitazone hydrochloride 33.07 mg (equivalent to 30 mg pioglitazone)

Dosage:

30 mg

forme pharmaceutique:

Tablet

Composition:

Active: Pioglitazone hydrochloride 33.07mg equivalent to 30 mg pioglitazone Excipient: Carmellose calcium Hyprolose Lactose monohydrate Magnesium stearate

Unités en paquet:

Blister pack, OPA/Al/PVC/Al (sample pack), 7 tablets

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Dr Reddy's Laboratories Limited

indications thérapeutiques:

Treatment of type 2 diabetes mellitus inadequately controlled by diet. Effective as a single agent and may also be used in combination with sulfonylureas, metformin, or insulin when diet plus the single agent does not result in adequate glycaemic control.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, OPA/Al/PVC/Al (sample pack) - 7 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, OPA/Al/PVC/Al - 28 tablets - 24 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

2011-10-14